Download PDF
CC BY-NC-ND 4.0 · Sleep Sci 2018; 11(02): 99-105
DOI: 10.5935/1984-0063.20180019
ORIGINAL ARTICLE

Insomnia and sexual dysfunction associated with severe worsening of the quality of life in sexually active hysterectomized women

Alvaro Monterrosa-Castro
1   Grupo de Investigación Salud de la Mujer, Facultad de Medicina. Universidad de Cartagena - Cartagena - Bolívar - Colombia.
,
Angélica Monterrosa-Blanco
2   Grupo de Investigación Salud de la Mujer, Facultad de Medicina Universidad de las Sabanas. Bogotá. - Bogotá - Cundinamarca - Colombia.
,
Teresa Beltrán-Barrios
1   Grupo de Investigación Salud de la Mujer, Facultad de Medicina. Universidad de Cartagena - Cartagena - Bolívar - Colombia.
› Author Affiliations
› Further Information
   Permissions and Reprints

Introduction

Hysterectomy is a common gynecologic surgery carried out to remove the pathologic uterus. Objective: To establish if sleep disorders and sexual function are associated with deterioration of the quality of life (QoL) in hysterectomized and sexually active women. Methods: A cross-sectional study was carried out with inhabitants from two cities of the Colombian Caribbean. The pollsters invited women aged between 40-59 years to participate; in their communities they applied surveys with demographic characteristics: Female Sexual Function Index, Atenas Insomnia Scale and Menopause Rating Scale. Sexually active women were selected; then the association was established with logistic regression. Results: 522 women were studied with an average age of 50 years: 30% oophorectomized, 59.8% Hispanic, 40.2% afro-descendants and 22.2% hormonal therapy users. 80% of them had somato/vegetative, psychological or urogenital deterioration; 29.1% with severe deterioration of QoL and 47.5% with insomnia. Out of 390 (74.7%) with sexual activity, 59.7% suffered from sexual dysfunction. Insomnia: OR:3.05 [95%CI:1.86-4.99], sexual dysfunction OR:3.52 [95%CI:2.01-6.17], dissatisfaction about sexuality OR:4.77 [95%CI:2.08-10.93], low or non-existent sexual desire OR:2.94 [95%CI:1.65-5.25], daytime drowsiness OR:3.15 [95%CI:1.59-6.24] and decrease in daytime well-being OR:3.18 [95%CI:1.79-5.64]. These were factors associated with severe worsening of QoL, while the presence of genital lubrication was protective, OR: 0.44 [95%CI:0.21-0.93],p=0.0332. Conclusion: It was observed that insomnia and sexual dysfunction behaved as factors associated with three times more severe deterioration of the QoL in climacteric and sexually active women previously hysterectomized.

Menopause, Quality of Life - Insomnia - Sleep - Climacteric - Hysterectomy


Publication History

Received: 09 January 2018

Accepted: 04 April 2018

Article published online:
13 October 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • REFERENCES

  • 1 Woods, NF. Quality of life among midlife women: globalization and women’s lives. Menopause. 2017;24(11):1217-8.
  • 2 Rannestad T. Hysterectomy: effects on quality of life and psychological aspects. Best Pract Res Clin Obstet Gynaecol. 2005;19(3):419-30.
  • 3 Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (Whoquol). Qual Life Res. 1993;2(2):153-9.
  • 4 Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes. 2004;2:45.
  • 5 Hess R, Thurston RC, Hays RD, Chang CC, Dillon SN, Ness RB, et al. The impact of menopause on health-related quality of life: results from the STRIDE longitudinal study. Qual Life Res. 2012;21(3):535-44.
  • 6 Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal Chang- Es) survey. J Sex Med. 2013;10(7):1790-9.
  • 7 Simon JA, Kokot-Kierepa M, Goldstein J, Nappi RE. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes Survey. Menopause. 2013;20(10):1043-8.
  • 8 Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). Maturitas. 2016;94:87-91.
  • 9 Kuppermann M, Learman LA, Schembri M, Gregorich SE, Jackson RA, Jacoby A, et al. Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life. Obstet Gynecol. 2013;122(1):15-25.
  • 10 Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res. 2003;55(3):263-7.
  • 11 Isidori A, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, et al. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med. 2010;7(3):1139-46.
  • 12 Rannestad T, Eikeland OJ, Helland H, Qvarnström U. Are the physiologically and psychosocially based symptoms in women suffering from gynecological disorders alleviated by means of hysterectomy? J Womens Health Gend Based Med. 2001;10(6):579-87.
  • 13 Kagan R. Surgical menopause: still confused after all these years. Menopause. 2012;19(5):491-3.
  • 14 Avis NE, Colvin A, Bromberger JT, Hess R, Matthews KA, Ory M, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women’s Health Across the Nation. Menopause. 2009;16(5):860-9.
  • 15 Saavedra-Orozco H, Monterrosa-Castro A, Caraballo-Olave E, Ulloque- Caamaño L, Rincón-Niño E. Prevalence of sexual dysfunction, insomnia and deterioration of the quality of life in hysterectomyzed women. Rev Cienc Biomed. 2014;5(2):235-46.
  • 16 Gallo Vallejo JL. Ovarian-conserving surgery versus bilateral oophorectomy in patients undergoing hysterectomy for benign processes. Clin Invest Ginecol Obstet. 2009;36(3):94-8.
  • 17 Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol. 2011;121(1):163-8.
  • 18 Hsia J, Barad D, Margolis K, Rodabough R, McGovernn PG, Limacher MC, et al.; Women’s Health Initiative Research Group. Usefulness of prior hysterectomy as an independent risk predictor of Framingham risk score (The Women’s Health Initiative). Am J Cardiol. 2003;92(3):264-9.
  • 19 Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20(9):888-902; quiz: 903-4.
  • 20 Thornton K, Chervenak J, Neal-Perry G. Menopause and Sexuality. Endocrinol Metab Clin North Am. 2015;44(3):649-61.
  • 21 Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause. 2006;13(1):46-56.
  • 22 Hummelen R, Macklaim JM, Bisanz JE, Hammond JA, McMillan A, Vongsa R, et al. Vaginal microbiome and epithelial gene array in postmenopausal women with moderate to severe dryness. PLoS One. 2011;6(11):e26602.
  • 23 Tan O, Bradshaw K, Carr BR. Management of vulvovaginal atrophyrelated sexual dysfunction in postmenopausal women: an up-to-date review. Menopause. 2012;19(1):109-17.
  • 24 Wysocki S, Kingsberg S, Krychman M. Management of Vaginal Atrophy: Implications from the REVIVE Survey. Clin Med Insights Reprod Health. 2014;8:23-30.
  • 25 Bruyneel M. Sleep disturbances in menopausal women: Aetiology and practical aspects. Maturitas. 2015;81(3):406-9.
  • 26 Guidozzi F. Sleep and sleep disorders in menopausal women. Climacteric. 2013;16(2):214-9.
  • 27 Manber R, Armitage R. Sex, steroids and sleep: a review. Sleep. 1999;22(5):540-55.
  • 28 Polo-Kantola P. Dealing with menopausal sleep disturbances. Sleep Med Clin. 2008;3(1):121-31.
  • 29 Eichling PS. Evaluating and treating menopausal sleep problems. Menopause Manag. 2002;11:8-16.
  • 30 Polo-Kantola P, Erkkola R, Irjala K, Pullinen S, Virtanen I, Polo O. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomised, double-blind crossover trial in postmenopausal women. Fertil Steril. 1999;71(5):873-80.
  • 31 Lord C, Sekerovic Z, Carrier J. Sleep regulation and sex hormones exposure in men and women across adulthood. Pathol Biol (Paris). 2014;62(5):302-10.
  • 32 Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7-10.